Somnuek SungkanuparphScott G. FillerPloenchan ChetchotisakdPeter G. PappasTracy L. NolenWeerawat ManosuthiThanomsak AnekthananonMichèle I. MorrisKhuanchai SupparatpinyoHeather KopetskieAmy S. KendrickPhilip C. JohnsonJack D. SobelRobert A. LarsenFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityMahidol UniversityKhon Kaen UniversityBamrasnaradura Infectious Diseases InstituteChiang Mai UniversityHarbor-UCLA Medical CenterUniversity of Southern CaliforniaUniversity of Miami Leonard M. Miller School of MedicineUniversity of AlabamaUniversity of Texas SystemWayne State UniversityFederal Systems DivisionFaculty of Medicine, Thammasat University2018-09-132018-09-132009-09-15Clinical Infectious Diseases. Vol.49, No.6 (2009), 931-934105848382-s2.0-70049116229https://repository.li.mahidol.ac.th/handle/20.500.14594/27933A prospective multicenter study of cryptococcal immune reconstitution inflammatory syndrome (IRIS) was conducted as a substudy of the Bacteriology and Mycology Study Group 3-01. Of 101 AIDS patients with cryptococcal meningitis who received highly active antiretroviral therapy (HAART), 13 experienced cryptococcal IRIS. No association between the timing of HAART initiation and the diagnosis of IRIS was identified. Increased baseline serum cryptococcal antigen (CrAg) titer was a risk factor for cryptococcal IRIS. © 2009 by the Infectious Diseases Society of America. All rights reserved.Mahidol UniversityMedicineArticleSCOPUS10.1086/605497